Dr. Reddy's officer files initial Form 3

Dr. Reddy's Laboratories Ltd officer Venkatesh Krishna, Global Head - IPDO, has filed an initial Form 3 as a reporting person.

Accepted by SEC EDGAR 04/01/2026 - 11:27 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Dr. Reddy's Laboratories Ltd officer Venkatesh Krishna, Global Head - IPDO, has filed an initial Form 3 as a reporting person. The filing in this excerpt lists no equity transactions or derivative positions, and serves mainly to establish his status as an insider subject to SEC reporting rules.

Key Terms

Form 3, Global Head - IPDO, reporting person

3 terms

Form 3 regulatory

"has filed an initial Form 3 as a reporting person"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

Global Head - IPDO financial

"officer title": "Global Head - IPDO""

reporting person regulatory

"as a reporting person under SEC rules"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 3 filed for RDY by Venkatesh Krishna show?

The Form 3 identifies Venkatesh Krishna, Global Head - IPDO at Dr. Reddy's Laboratories, as a reporting person. In this excerpt, it lists no equity transactions or derivative positions, serving mainly to establish his insider reporting status.

Did the RDY Form 3 for Venkatesh Krishna report any share purchases or sales?

No, this Form 3 excerpt for Dr. Reddy's Laboratories officer Venkatesh Krishna shows no reported share purchases, sales, or other equity transactions. All transaction-related summary counts, including buys, sells, and exercises, are recorded as zero in the data provided.

What role does Venkatesh Krishna hold at Dr. Reddy's Laboratories (RDY)?

Venkatesh Krishna is listed as an officer of Dr. Reddy's Laboratories with the title Global Head - IPDO. This officer status makes him a reporting person under SEC rules, requiring beneficial ownership reporting such as this Form 3 filing.

Are any derivative securities reported for RDY in this Form 3 excerpt?

No derivative securities are shown in this Form 3 excerpt for Dr. Reddy's Laboratories. The derivativeSummary is empty and the derivativeTransactionCount is zero, indicating no options, warrants, or similar instruments are reported here for Venkatesh Krishna.

Does the RDY Form 3 excerpt indicate any gifts or tax-withholding transactions?

The Form 3 excerpt for Dr. Reddy's Laboratories officer Venkatesh Krishna reports zero gift transactions and zero tax-withholding entries. The counts for giftShares and taxWithholdingShares are also zero, indicating no such movements are disclosed in this dataset.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

VENKATESH KRISHNA

(Last) (First) (Middle)

TOWER A 604, PLOT NO: 3,

KNOWLEDGE CITY, RAIDURG

(Street)

HYDERABAD TELANGANA 500049

(City) (State) (Zip)

INDIA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
12/18/2025

3. Issuer Name and Ticker or Trading Symbol
DR REDDYS LABORATORIES LTD [ RDY ]

3a. Foreign Trading Symbol
[DRREDDY&500124]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Global Head - IPDO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ KRISHNA VENKATESH	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)